Limitations, agreements, and source contact

High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma · Source last updated 2023-08-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restrictive Agreement

false

point Of Contact

email

bechen@ctg.queensu.ca

organization

Canadian Cancer Trials Group

phone

613-533-6000

phone Ext

77703

title

Bingshu Chen

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice